
Sprouts Reports Q3 Net Income of $113.4 Million and Sets Fourth-Quarter Outlook
Net income fell to $113.4 million from $120.1 million, and the company guided to fourth-quarter diluted EPS of $0.47 to $0.51.

Net income fell to $113.4 million from $120.1 million, and the company guided to fourth-quarter diluted EPS of $0.47 to $0.51.

The restatement stems from a $150 million Scilex equity sale paid in Bitcoin, which the company now treats as a subscription receivable rather than a digital asset.

The take-private deal values the outpatient surgery operator at about $5.7 billion enterprise value and is expected to close in the first quarter of 2027.